Health Care & Life Sciences » Biotechnology | Shanghai RAAS Blood Products Co. Ltd.

Shanghai RAAS Blood Products Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
430
1,452
3,532
4,243
4,532
1,191
Total Accounts Receivable
135
489
547
1,009
1,232
1,029
Inventories
290
695
716
803
1,155
1,682
Other Current Assets
42
31
13
18
20
11
Total Current Assets
896
2,667
4,807
6,073
6,939
3,912
Net Property, Plant & Equipment
579
1,077
1,096
1,185
1,140
1,126
Total Investments and Advances
-
-
-
-
382
354
Intangible Assets
48
5,583
5,582
5,877
5,912
5,714
Other Assets
39
35
39
66
52
69
Total Assets
1,575
9,379
11,556
13,226
14,455
11,387
ST Debt & Current Portion LT Debt
-
-
34
41
360
Accounts Payable
53
71
39
49
42
Income Tax Payable
10
63
54
167
57
Other Current Liabilities
26
139
119
614
205
Total Current Liabilities
90
273
247
871
664
Long-Term Debt
357
358
360
360
-
Deferred Taxes
12
3
112
151
115
Other Liabilities
-
52
-
-
1,096
Total Liabilities
447
696
750
1,408
1,906
Common Equity (Total)
1,087
8,610
10,658
11,709
12,462
Total Shareholders' Equity
1,087
8,610
10,658
11,709
12,462
Total Equity
1,102
8,624
10,712
11,730
12,480
Liabilities & Shareholders' Equity
1,575
9,379
11,556
13,226
14,455
Accumulated Minority Interest
15
15
54
22
18
Non-Equity Reserves
27
59
94
88
70

About Shanghai RAAS Blood Products Co.

View Profile
Address
No. 2009 Wangyuan Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.raas-corp.com
Updated 07/08/2019
Shanghai RAAS Blood Products Co., Ltd. engages in the production and sale of blood products. It provides testing services for blood, vaccines, diagnostic reagents, and testing equipment. Its products include human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.